Journal
Journal of Clinical Pharmacy and Therapeutics (JCPT): Vol. 44 (3) June 2019
The articles discussed in this edition are as follows:
1. Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer’s disease
2. Potentially inappropriate medications with risk of cardiovascular adverse events in the elderly: A systematic review of tools addressing inappropriate prescribing
3. Treating opioid‐induced constipation in patients taking other medications: Avoiding CYP450 drug interactions
4. Ifosfamide‐induced encephalopathy: Brand‐name (HOLOXAN®) vs generic formulation (IFOSFAMIDE EG®)
5. A case of simvastatin‐induced myopathy with SLCO1B1 genetic predisposition and co‐ingestion of linagliptin and Stevia rebaudiana
6. Network meta‐analysis of tofacitinib versus biologic treatments in moderate‐to‐severe rheumatoid arthritis patients
7. Prevention of post‐operative hyperalgesia in a heroin‐addicted patient on methadone maintenance
8. A drug utilization study to evaluate effectiveness of risk minimization measures for trimetazidine in France, Hungary, Romania and Spain
9. Rapid attainment of target trough concentrations of tacrolimus for early improvement of clinical symptoms in patients with ulcerative colitis
10. Polymyxin B clinical outcomes: A prospective study of patients undergoing intravenous treatment
11. Efficacy and safety of ipilimumab for treating advanced melanoma: A systematic review and meta‐analysis
12. Development and content validation of an instrument to document the dispensing of prescribed medicines
13. Paediatric acute kidney injury induced by vancomycin monotherapy versus combined vancomycin and meropenem
14. Effect of cyclosporine A versus tacrolimus on the response to antiviral therapy after hepatitis C genotype‐4 recurrence post–liver transplantation: A prospective cohort trial
15. The impact of implementing an antifungal stewardship with monitoring of 1‐3, β‐D‐glucan values on antifungal consumption and clinical outcomes
16. Female low dose tip syringes‐increased complexity of use may compromise dosing accuracy in paediatric patients
17. Adherence to guidelines for pharmacological treatment of young adults with myocardial infarction in Poland: Data from Polish Registry of Acute Coronary Syndromes (PL‐ACS)
18. Successful treatment of seizure disorder by evaluating phenobarbital clearance in a paediatric patient undergoing continuous haemodiafiltration
19. Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: A report of two cases
20. Rapid subcutaneous desensitization for the management of delayed hypersensitivity reactions to omalizumab:A case report
21. Drug information centres and their provision of decision support: The Scandinavian experience
22. Haemorrhagic gastric hyperplastic polyps associated with long‐term use of proton pump inhibitor in a case without Helicobacter pylori infection
Tidak tersedia versi lain